|
|
|
| Effect evaluation of clinical pathway of 10 diseases in a tertiary hospital in Guangxi |
| Zhou Hongzhen, Wu Yunhong, Teng Yanfei, Zhou Lin, Wei Mingchao, Wei Fang. |
| The Second Affiliated Hospital of Guangxi Medical University, Nanning 530007, China |
|
|
|
Abstract Objective To evaluate the implementation effect of clinical pathways of 10 diseases in a tertiary hospital in Guangxi. Methods Ten diseases of new clinical pathways from January to June 2018 were selected, and the cases within the previous year of the implementation of clinical pathway were put into the control group, and the cases within one year after the implementation of the clinical pathway were put into the pathway group.The hospitalization days, hospitalization expenses, and disease outcomes of the two groups were compared. Results Totally 1 133 cases were included in the pathway group and 914 cases were included in the control group. The hospitalization days, total expenses and drug proportion in the pathway group were smaller than those in the control group, and the treatment efficiency in the pathway group was higher than that in the control group,with the differences statistically significant (P<0.05). Some indexes of diseases did not achieve the expected effects after the clinical pathway was implemented. The hospitalization days and drug proportion in the pathway group of cerebral ischemic diseases were higher than those in the control group, the total expenses of the pathway group of the phimosis day surgery were larger than that of the control group, the drug proportion of the pathway group of the craniocerebral injury and ureteral stent was higher than that of the control group, the material proportion of the pathway group of schizophrenia and cervical masses day surgery was larger than that of the control group,and the differences were statistically significant (P<0.05). Conclusion The hospital has achieved certain results in implementing the clinical pathway, but some problems still need to be improved. The hospital can take targeted improvement measures to improve the relevant processes of the clinical pathway.
|
|
Received: 18 March 2020
|
|
|
|
［1］临床路径编委会.临床路径管理汇编［G］.北京:科学技术出版社,2010:1-9.
［2］薛允莲.临床路径管理前后全髋关节置换术患者药占比的中断时间序列分析［J］.中国卫生统计,2018,35(3):413-414.
［3］王丹,邢沫.5个肿瘤病种实施临床路径对缩短住院日和降低次均费用的效果分析［J］.中国医院,2013,17(10):32-33.
［4］任晓红,徐云莉,毛山,等.临床路径对基层医院呼吸专科病房成本控制的影响研究［J/OL］.［2020-03-18］.中国全科医学,2019,22(25):14.http://kns. cnki.net/kcms/detail/13.1222.R. 20190805.2012.038.html.
［5］刘文雅,魏文斌,宋旭东,等.老年性白内障日间手术临床路径模式效果分析［J］.中国医院管理,2017,37(9):42-44.
［6］乐新,刘敏,蒲春涛,等.临床路径管理对住院天数和住院费用的影响分析［J］.中国病案,2017,18(5):31-33.
［7］肖敏,蔡乐,卢俊丽,等.临床路径管理在外科手术中的实施效果观察［J］.中国临床新医学,2018,11(6):538-541.
［8］戈志强.四病种实施临床路径改革效果研究［D］.南京:南京中医药大学,2017.
［9］曹丙艳,刘钢.2017年泰安市某医院临床路径实施效果评价分析［J］.中国医院统计,2018,25(5):370-372. |
| [1] |
Liao Jierong,Lin Denan. Analysis of hospitalization expense of missed abortion patients in clinical pathway from tertiary hospitals[J]. journal1, 2020, 27(3): 221-225. |
| [2] |
Zhang Yaoguang,, Miao Zhiwen1, Zhou Zhongliang2, Xue Ming1, Xu Ling3. . Effect evaluation of pilot reform of countylevel public hospitals based on propensity score matching[J]. journal1, 2020, 27(1): 70-73. |
| [3] |
Fan Jingjing, Huang Xiandan, Wang Haini. Effectiveness evaluation of clinical health education pathway application in cirrhotic ascites patients[J]. journal1, 2019, 26(4): 304-306. |
| [4] |
Gu Xiaoming, Shi Quan, Lu Yi. Effect of information based transformation and optimization of clinical pathway in a hospital[J]. journal1, 2019, 26(3): 186-189. |
| [5] |
Lin Denan, Liao Jierong. Implementation quality analysis of missed abortion clinical pathway[J]. journal1, 2019, 26(3): 195-198. |
| [6] |
Wu Huatun, Huang Xiaoguang, Zhu Jianqian. Effectiveness analysis on clinical pathway of common bile duct stones day surgery[J]. journal1, 2019, 26(1): 30-33. |
|
|
|
|
